关于我们
Didadem Biotherapeutics is pioneering the development of first-in-class engineered exosomes to treat auto-immune conditions and cancers.
- 网站
-
https://diadembio.com
Diadem Biotherapeutics的外部链接
- 所属行业
- 生物技术
- 规模
- 2-10 人
- 总部
- Torrance,California
- 类型
- 私人持股
- 创立
- 2019
- 领域
- Biotechnology和Therapeutics
地点
Diadem Biotherapeutics员工
动态
-
Attending BIO international next week? We're on the partnering app: https://lnkd.in/dsXkBiA Let's discuss how our multivalent biologic display capabilities can: - improve the potency AND efficacy of your agonist antibody or ligand fusion protein. - enhance the payload delivery AND specificity of your ADC for improved killing. - rapidly prototype and test cell engagers from monoclonal antibody pairs. - generate in situ CAR-X through cell-specific delivery. - combine multiple targets in the cancer immunity cycle using one vehicle.
-
Less than two weeks until #BIO2024?powered by our friends?Biotechnology Innovation Organization?in sunny ???#SanDiego. We're ready to partner! Diadem is pioneering a novel approach in immunotherapy by engineering cell-derived vesicles and immuno-liposomes with lipid-bound multivalent ligands, aimed to precisely modulate immune cell signaling and enhance responses against tumors and autoimmune disorders. With capabilities including functionalization of vesicles with surface or cargo proteins, post-production assembly for tunable loading with recombinant proteins, peptides, oligonucleotides, or chemotherapeutics, and a plug-and-play universal antibody display, our mission is to revolutionize the landscape of immunotherapy. https://diadembio.com
-
Have you invested in #ExtracellularVesicles, also known as #Exosomes? Are you wondering why it's taking so long to see any returns? Or perhaps you're questioning why your startup hasn't delivered on the promises made during its pitch? Join our webinar, 'Investing in Bubbles: Are Extracellular Vesicles Flops or Pops?' to discover answers to these questions and more about exosome-focused startups. Click the link below to register: https://lnkd.in/dEaKrjzj #Biotech #Investing #HealthTech #StartupInvesting #VentureCapital #InnovationInHealthcare #MedicalResearch #LifeSciences #BiotechInvesting #StartupInvesting #HealthcareInnovation #InvestmentOpportunity #Aging